PaxMedica Accelerates RSU Vesting for Top Executives
Company Announcements

PaxMedica Accelerates RSU Vesting for Top Executives

PaxMedica, Inc. (PXMD) has released an update to notify the public and investors about its officers.

PaxMedica, Inc.’s Board approved the acceleration of vesting for certain restricted stock units (RSUs) to lessen administrative burdens. Key executives, including President and CEO Howard Weisman, CFO and COO Stephen Sheldon, and Chief Medical Officer Dr. David Hough, will benefit from this acceleration. The accelerated RSUs, whose values are based on the company’s closing stock price, will fully vest the day after the annual report is filed, contingent upon continued employment.

For further insights into PXMD corporate activity, check out TipRanks’ Insiders Trading Activity page.

Related Articles
TheFlyPaxMedica secures immediate exercise of warrants
TheFlyPaxMedica reports first patient treated with PAX-101 for HAT
TheFlyPaxMedica files Nasdaq delisting appeal notice
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App